| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.40B | +15.7% |
| Cost of Revenue | $3.26B | +13.8% |
| Gross Profit | $3.14B | +17.8% |
| R&D Expense | $368.1M | +7.8% |
| SG&A Expense | $390.1M | -10.0% |
| Operating Income | $920.3M | +42.9% |
| Pre-tax Income | $900.3M | +57.3% |
| Income Tax | $198.9M | +48.7% |
| Net Income | $701.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $777.3M | +113.7% |
| Accounts Receivable | $1.67B | +31.6% |
| Inventory | $1.00B | +11.4% |
| Current Assets | $3.61B | +36.6% |
| Total Assets | $5.35B | +21.7% |
| Current Liabilities | $1.77B | +16.0% |
| Long-term Debt | $696.8M | -5.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $634.1M | +42.0% |
| Capital Expenditures | $146.1M | +6.1% |
| Investing Cash Flow | -$159.8M | -5.7% |
| Financing Cash Flow | -$77.1M | +5.1% |
| Free Cash Flow | $488.1M | +58.0% |
| +59.9% |
| EPS (Basic) | $4.97 | +58.3% |
| EPS (Diluted) | $4.94 | +58.8% |
| Total Liabilities |
| $2.67B |
| +8.7% |
| Stockholders' Equity | $2.68B | +38.2% |